Vidyya Medical News Service
Volume 5 Issue 277 Published - 14:00 UTC 08:00 EST 4-Oct-2003 Next Update - 14:00 UTC 08:00 EST 5-Oct-2003
little clear gif used for spacer

FDA approves first new drug application for treatment of radiation contamination due to cesium or thallium
Yesterday, the Food and Drug Administration (FDA) approved a New Drug Application for Radiogardase, also known as Prussian blue, to treat people exposed to radiation contamination, due to harmful levels of cesium-137 or thallium. Radiogardase capsules contain Ferric (III) hexacyanoferrate(II).  more

PTH and Alendronate: Combining treatments shows no bone density advantage
Combining the bone-building treatment parathyroid hormone (PTH) with alendronate, a drug that slows bone loss, produces no significant improvement in bone mineral density (BMD) beyond that produced by the individual drugs, according to two new studies involving postmenopausal women and men with low BMD.  more


Damage to the frontal lobes can affect a person's ability to 'stay on the job'
A new study sheds light on why brain injury patients have difficulty performing tasks consistently -- a necessary requirement for holding a job. The findings may influence how clinical assessments of brain injury are conducted in future, encouraging doctors to pay closer attention to 'variability' of performance as a marker for impairment.  more

Research breakthrough in understanding treatment resistant depression
Around 5 million people in the UK experience depression at any one time. Whilst a number of successful treatments, both pharmacological and psychotherapeutic, are available and many people make a full recovery about 30 40% of people are resistant to conventional therapies. For them their depression is an enduring, debilitating disease and for some, the only treatment options left include psychosurgery and ECT.  more

Stanford computer model shows bypass surgery more cost-effective than stents
Stanford University Medical Center researchers have developed a computer model showing that bypass surgery is more cost-effective in the long run than stents in patients with two or more blocked coronary arteries. Not only does surgery ultimately cost less but it results in a better quality of life, including less chest pain. The results hold even when comparing surgery to newer stents coated with drugs to keep vessels from re-narrowing.  more

little clear gif used for a space